REGENXBIO Inc. (FRA:RB0)
Germany · Delayed Price · Currency is EUR 11.40
+0.10 (0.88%)
At close: Nov 28, 2025
REGENXBIO Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -177.92 | -227.1 | -263.49 | -280.32 | 127.84 | -111.25 | Upgrade |
Depreciation & Amortization | 15.77 | 16.22 | 17.32 | 12.91 | 9.56 | 8.41 | Upgrade |
Asset Writedown & Restructuring Costs | - | 2.1 | - | - | - | - | Upgrade |
Loss (Gain) From Sale of Investments | -12.05 | -10.76 | -1.52 | 4.79 | 0.65 | -3.84 | Upgrade |
Stock-Based Compensation | 35.73 | 38.46 | 40.27 | 40.79 | 38.81 | 31.95 | Upgrade |
Provision & Write-off of Bad Debts | -5 | -5 | - | - | -2.57 | 7.68 | Upgrade |
Other Operating Activities | 14.93 | 7.43 | -0.1 | 0.37 | 4.36 | -1.23 | Upgrade |
Change in Accounts Receivable | 1.03 | 9.71 | 3.94 | 4.82 | 14.12 | -9.9 | Upgrade |
Change in Accounts Payable | 2.62 | -0.29 | -2.79 | 18.79 | -2.3 | 3.87 | Upgrade |
Change in Unearned Revenue | 34.24 | -0.03 | -1.51 | -1.17 | -0.9 | - | Upgrade |
Change in Other Net Operating Assets | -12.65 | -3.85 | -10.52 | -8.47 | 29.3 | 20.24 | Upgrade |
Operating Cash Flow | -103.3 | -173.13 | -218.41 | -207.49 | 218.88 | -54.06 | Upgrade |
Capital Expenditures | -2.99 | -2.44 | -9.96 | -30.72 | -84.18 | -26.87 | Upgrade |
Investment in Securities | -10.15 | 105.88 | 200.9 | 18.8 | -322.47 | 149.63 | Upgrade |
Investing Cash Flow | -13.13 | 103.45 | 190.94 | -11.93 | -406.64 | 122.76 | Upgrade |
Issuance of Common Stock | 1.31 | 133.77 | 8.22 | 4.55 | 222.49 | 7.42 | Upgrade |
Repurchase of Common Stock | -0.63 | -0.91 | -0.42 | -0.28 | -0 | - | Upgrade |
Other Financing Activities | 117.93 | -40.18 | -42.77 | -33.1 | -27.24 | 192.79 | Upgrade |
Financing Cash Flow | 118.62 | 92.68 | -34.97 | -28.84 | 195.25 | 200.21 | Upgrade |
Net Cash Flow | 2.19 | 23 | -62.43 | -248.26 | 7.48 | 268.91 | Upgrade |
Free Cash Flow | -106.28 | -175.56 | -228.37 | -238.21 | 134.7 | -80.93 | Upgrade |
Free Cash Flow Margin | -65.88% | -210.69% | -253.06% | -211.32% | 28.64% | -52.36% | Upgrade |
Free Cash Flow Per Share | -2.07 | -3.55 | -5.22 | -5.52 | 3.07 | -2.17 | Upgrade |
Cash Interest Paid | 6.56 | 6.56 | 7.28 | 23.12 | 21.64 | - | Upgrade |
Cash Income Tax Paid | - | -0.07 | -0.14 | 11.81 | 6 | -0.19 | Upgrade |
Levered Free Cash Flow | -69.02 | -95.45 | -133.51 | -156.11 | 72.51 | -39.25 | Upgrade |
Unlevered Free Cash Flow | -42.67 | -87.54 | -129.22 | -141.58 | 88.93 | -38.77 | Upgrade |
Change in Working Capital | 25.24 | 5.53 | -10.89 | 13.98 | 40.22 | 14.22 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.